About Danguole Altman
Form D filings for Cx Precision Medicine from 2020 to 2024 list Danguole Altman as president and CEO, director.
Danguole Altman first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Danguole Altman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Danguole Altman works with at each company, as listed on that company's latest Form D.
Cx Precision Medicine, Inc. · Form D, Jun 26, 2024
DB
Darlene Boudreaux
Executive officer
CC
Cameron Cushman
Director
RF
Robert Ferguson
Director
EL
Edward Lasater
Director
DK
Donald Keyser
Director